Archibald S. Perkins

Archibald S. Perkins

Auto-generated profile, based on publicly available information

Archibald S. Perkins

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
BFBenjamin J. Frisch
Benjamin J. Frisch
CHCorey M. Hoffman
Corey M. Hoffman
SLSarah E. Latchney
Sarah E. Latchney
MLMark W. LaMere
Mark W. LaMere
JMJason Myers
Jason Myers
LCLaura Maria Calvi
Laura Maria Calvi
The bone marrow microenvironment contributes to the regulation of hematopoietic stem cell (HSC) function, though its role in age-associated lineage skewing is poorly understood. Here we show that dysfunction of aged marrow macrophages (Mφs) directs HSC platelet bias. Mφs from the marrow of aged mice and humans exhibited an activated phenotype, with increased expression of inflammatory signals. Aged marrow Mφs also displayed decreased phagocytic function. Senescent neutrophils, typically cleared by marrow Mφs, were markedly increased in aged mice, consistent with functional defects in Mφ phagocytosis and efferocytosis. In aged mice, interleukin-1B (IL-1B) was elevated in the bone marrow, and caspase-1 activity, which can process pro–IL-1B, was increased in marrow Mφs and neutrophils. Mechanistically, IL-1B signaling was necessary and sufficient to induce a platelet bias in HSCs. In young mice, depletion of phagocytic cell populations or loss of the efferocytic receptor Axl expanded platelet-biased HSCs. Our data support a model wherein increased inflammatory signals and decreased phagocytic function of aged marrow Mφs induce the acquisition of platelet bias in aged HSCs. This work highlights the instructive role of Mφs and IL-1B in the age-associated lineage skewing of HSCs, and reveals the therapeutic potential of their manipulation as antigeronic targets.

6 October 2011 in Blood
Verified
Journal Article
Open access
PDF file
YZYi Zhang
Yi Zhang
SSSandra Stehling-Sun
Sandra Stehling-Sun
KLKimberly Lezon-Geyda
Kimberly Lezon-Geyda
SJSubhash C. Juneja
Subhash C. Juneja
LCLucie Coillard
Lucie Coillard
APArchibald S. Perkins
Archibald S. Perkins
The Mds1 and Evi1 complex locus (Mecom) gives rise to several alternative transcripts implicated in leukemogenesis. However, the contribution that Me

27 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGCarolyn Glass
Carolyn Glass
CWCharles Wuertzer
Charles Wuertzer
XCXiaohui Cui
Xiaohui Cui
YBYingtao Bi
Yingtao Bi
RDRamana Davuluri
Ramana Davuluri
APArchibald Perkins
Archibald Perkins
The ecotropic virus integration site 1 (EVI1) transcription factor is associated with human myeloid malignancy of poor prognosis and is overexpressed in 8–10% of adult AML and strikingly up to 27% of pediatric MLL-rearranged leukemias. For the first time, we report comprehensive genomewide EVI1 binding and whole transcriptome gene deregulation in leukemic cells using a combination of ChIP-Seq and RNA-Seq expression profiling. We found disruption of terminal myeloid differentiation and cell cycle regulation to be prominent in EVI-induced leukemogenesis. Specifically, we identified EVI1 directly binds to and downregulates the master myeloid differentiation gene Cebpe and several of its downstream gene targets critical for terminal myeloid differentiation. We also found EVI1 binds to and downregulates Serpinb2 as well as numerous genes involved in the Jak-Stat signaling pathway. Finally, we identified decreased expression of several ATP-dependent P2X purinoreceptors genes involved in apoptosis mechanisms. These findings provide a foundation for future study of potential therapeutic gene targets for EVI1-induced leukemia.

1 June 2014 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
CGCarolyn Glass
Carolyn Glass
MWMichael Wilson
Michael Wilson
RGRuby Gonzalez
Ruby Gonzalez
YZYi Zhang
Yi Zhang
APArchibald S. Perkins
Archibald S. Perkins

12 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
EAEdward Ayoub
Edward Ayoub
MWMichael P. Wilson
Michael P. Wilson
KMKathleen E. McGrath
Kathleen E. McGrath
ALAllison J. Li
Allison J. Li
BFBenjamin J. Frisch
Benjamin J. Frisch
APArchibald S. Perkins
Archibald S. Perkins
Inv(3q26) and t(3:3)(q21;q26) are specific to poor-prognosis myeloid malignancies, and result in marked overexpression of EVI1, a zinc-finger transcription factor and myeloid-specific oncoprotein. Despite extensive study, the mechanism by which EVI1 contributes to myeloid malignancy remains unclear. Here we describe a new mouse model that mimics the transcriptional effects of 3q26 rearrangement. We show that EVI1 overexpression causes global distortion of hematopoiesis, with suppression of erythropoiesis and lymphopoiesis, and marked premalignant expansion of myelopoiesis that eventually results in leukemic transformation. We show that myeloid skewing is dependent on DNA binding by EVI1, which upregulates Spi1, encoding master myeloid regulator PU.1. We show that EVI1 binds to the −14 kb upstream regulatory element (−14kbURE) at Spi1; knockdown of Spi1 dampens the myeloid skewing. Furthermore, deletion of the −14kbURE at Spi1 abrogates the effects of EVI1 on hematopoietic stem cells. These findings support a novel mechanism of leukemogenesis through EVI1 overexpression.

1 November 2011 in Biochemistry
Verified
Journal Article
Closed access
YZYi Zhang
Yi Zhang
GSGéraldine Sicot
Géraldine Sicot
XCXiaohui Cui
Xiaohui Cui
MVMarion Vogel
Marion Vogel
CWCharles A. Wuertzer
Charles A. Wuertzer
APArchibald S. Perkins
Archibald S. Perkins